ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer's disease: Strategies and research directions.

Jeffrey L CummingsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.